Next‑Generation Sequencing (NGS)

What Is Next‑Generation Sequencing (NGS)?

Next‑Generation Sequencing (NGS) is an advanced DNA sequencing technology that allows scientists and clinicians to analyse large amounts of genetic material quickly and accurately. Unlike traditional sequencing methods that read one DNA fragment at a time, NGS can sequence millions of DNA fragments simultaneously. This high‑throughput capability makes it possible to study entire genomes, specific gene panels, or all protein‑coding regions of DNA in a single analysis.

The development of NGS has transformed modern genetic research and clinical diagnostics. By providing detailed insights into genetic variations, mutations, and inherited conditions, this technology helps researchers better understand the genetic basis of many diseases. As a result, NGS has become a powerful tool in areas such as cancer genomics, rare disease investigation, and precision medicine.

In clinical practice, NGS is widely used in Congenital Abnormalities Genetic Testing, where it helps identify genetic mutations responsible for developmental disorders and inherited conditions. Early detection through advanced sequencing technologies can support accurate diagnosis and guide appropriate medical management.

Furthermore, NGS plays a significant role in Genomic Medicine in Paediatrics, enabling clinicians to investigate complex genetic conditions affecting infants and children. By analysing a patient’s genetic information in detail, healthcare professionals can better understand disease mechanisms and develop more personalised approaches to treatment and care.

Overall, NGS represents a major advancement in genomic science, providing faster, more comprehensive, and more precise analysis of genetic information than ever before.

Types of NGS Approaches: Whole Genome, Exome, and Targeted Sequencing

Understanding the Main Strategies Used in Modern Genomic Analysis

Next‑Generation Sequencing (NGS) can be applied in several different ways depending on the clinical question, research aim, or level of detail required. Although all NGS approaches rely on the same core sequencing principles, they vary in terms of scope, cost, and the amount of information they provide. The three most widely used strategies in genomic medicine are Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and Targeted Sequencing.

1. Whole Genome Sequencing (WGS)

Whole Genome Sequencing reads the entire DNA sequence of an individual, including both coding and non‑coding regions.

Because WGS covers every part of the genome, it provides the most comprehensive insight into genetic variation. This includes single‑letter changes, structural rearrangements, copy‑number differences, and variants in regulatory regions that might influence gene expression.

Although WGS is more expensive and generates very large datasets, it is invaluable when a condition remains undiagnosed after other tests or when a broad genomic overview is required.

2. Whole Exome Sequencing (WES)

Whole Exome Sequencing focuses only on the exome—the protein‑coding regions of the genome, which make up just 1–2% of the entire DNA sequence.

Most known disease‑causing mutations occur within these coding regions, which makes WES a highly efficient and cost‑effective diagnostic tool, particularly in paediatric genetics and rare disease investigation.

WES provides a strong balance between detail, cost, and turnaround time, making it one of the most commonly used NGS approaches in clinical settings.

3. Targeted Sequencing

Targeted Sequencing analyses a specific set of genes or genomic regions associated with a particular condition or clinical question.

Examples include cancer panels, cardiomyopathy panels, and tests focused on metabolic or neurological disorders. By concentrating only on relevant genes, targeted sequencing is faster, more affordable, and often more sensitive, as it provides deeper coverage of the selected regions.

This approach is especially useful when clinicians suspect a particular disorder or when guidelines recommend testing a defined group of genes.

Clinical Applications of NGS in Genetic Testing and Medicine

Next‑Generation Sequencing (NGS) has become a key technology in modern genetic testing because it can
identify many types of DNA variations quickly and at scale. In clinical practice, NGS allows healthcare
professionals to move beyond trial‑and‑error approaches toward more targeted and personalised medical decisions.
Today, it is widely used across fields such as medical genetics, oncology, and precision medicine.

Explore the major clinical uses of Next‑Generation Sequencing in modern medicine.

Diagnosis of Rare Genetic Conditions

Identifying the genetic causes of rare or undiagnosed disorders.

Role: NGS allows clinicians to analyse many genes simultaneously when patients show symptoms
suggesting a genetic disorder.

Impact: It can reveal disease‑causing variants that traditional single‑gene tests may miss,
leading to faster diagnosis, improved clinical management, and better understanding of the condition.

Carrier Screening and Family Planning

Detecting inherited variants that could be passed to children.

Role: NGS can identify whether individuals carry genetic variants linked to inherited diseases.

Impact: This information helps couples make informed reproductive decisions and may guide
further genetic counselling or reproductive options.

Pharmacogenetics and Personalised Medicine

Guiding drug choice and dosage using genetic information.

Role: NGS can identify genetic variants that influence how the body metabolises medications.

Impact: These insights help clinicians select safer drugs, optimise dosing, and reduce the risk
of adverse drug reactions, supporting more personalised treatment strategies.

Cancer Genomics and Targeted Therapy

Detecting tumour mutations that guide treatment decisions.

Role: NGS analyses tumour DNA to identify mutations, gene fusions, or other genomic changes.

Impact: This information helps doctors determine whether a patient may benefit from targeted
therapies, immunotherapy, or specific treatment strategies.

Inborn Errors of Metabolism

Detecting genetic causes of metabolic disorders.

Role: Many metabolic diseases result from inherited mutations affecting enzyme function.

Impact: NGS can identify these mutations quickly, allowing clinicians to confirm diagnoses
and begin dietary or medical treatments earlier.

Prenatal and Reproductive Genetic Testing

Analysing fetal DNA to identify potential genetic conditions.

Role: NGS can be used to analyse fetal genetic material during pregnancy,
depending on clinical protocols.

Impact: Results help healthcare providers and families understand potential risks
and plan appropriate care, usually alongside genetic counselling.

Newborn Genetic Screening

Early detection of inherited disorders in newborns.

Role: In some healthcare systems, NGS is used to detect genetic disorders shortly after birth.

Impact: Early identification allows timely medical intervention, which can prevent
serious complications and significantly improve long‑term health outcomes.

Key Takeaway:

Next‑Generation Sequencing (NGS) has transformed clinical genetics by enabling rapid and
comprehensive analysis of the human genome. It supports the diagnosis of rare diseases,
guides personalised drug therapy, improves cancer treatment strategies, and assists
with reproductive and newborn genetic testing.

By providing detailed genetic insights, NGS plays a central role in the advancement of
precision medicine and more personalised healthcare.

Advantages of NGS Compared to Traditional DNA Sequencing

Next‑Generation Sequencing (NGS) offers several important advantages over traditional DNA sequencing methods, particularly the classic Sanger sequencing approach. While Sanger sequencing was a groundbreaking technology and remains useful for confirming specific variants, NGS has transformed genetic research and clinical testing by making large‑scale sequencing faster, more comprehensive, and more efficient.

1. High‑Throughput Sequencing

One of the most significant advantages of NGS is its massively parallel sequencing capability. Traditional sequencing methods analyse DNA fragments one at a time, whereas NGS can sequence millions of DNA fragments simultaneously.

This high‑throughput capacity allows laboratories to analyse entire genomes or large gene panels within a single experiment.

2. Faster Processing Time

Because NGS processes large numbers of DNA fragments at once, it significantly reduces the time required for genetic analysis. What once took weeks or months with traditional methods can now often be completed in days, depending on the scale of the test.

3. Greater Genetic Coverage

Traditional sequencing typically focuses on a single gene or small DNA region, whereas NGS can examine large portions of the genome—including hundreds or thousands of genes in one test.

This broader coverage increases the likelihood of identifying disease‑causing variants.

4. Cost Efficiency for Large‑Scale Testing

Although NGS platforms require advanced equipment, the cost per base sequenced is much lower compared to traditional sequencing when analysing large genomic regions. This makes NGS more economical for comprehensive genetic testing.

5. Detection of Multiple Variant Types

NGS can identify a wide range of genetic changes, including:

• single nucleotide variants (SNVs)
• insertions and deletions (indels)
• copy number variations (CNVs)
• structural variants in some platforms

Traditional sequencing methods are more limited in detecting these complex variations.

6. Better Suitability for Precision Medicine

Because NGS can analyse many genes simultaneously and detect multiple variant types, it is particularly well suited for precision medicine. Clinicians can use this information to guide diagnosis, predict disease risk, and select treatments that are more tailored to individual patients.

Challenges and Limitations of NGS Technology

Although Next‑Generation Sequencing (NGS) has transformed genetic analysis, it still comes with technical, clinical, and practical limitations that laboratories and clinicians must consider. These challenges do not reduce the value of NGS, but they highlight the need for careful interpretation, high‑quality laboratory workflows, and proper clinical context.

1. Complexity of Data Analysis

NGS generates extremely large datasets, often millions of DNA reads.

Interpreting this data requires:

• advanced bioinformatics tools
• high‑performance computing systems
• experienced analysts

Even after processing the data, determining which genetic variants are truly disease‑causing can be difficult, especially in large genomes.

2. Possibility of False Positives and False Negatives

NGS is powerful, but not perfect. Errors can occur due to:

• short read lengths
• sequencing chemistry limitations
• alignment issues
• low coverage in certain genomic regions

For this reason, important findings—especially clinically actionable variants—often need to be confirmed with Sanger sequencing.

3. Uneven Coverage of the Genome

NGS does not sequence all regions equally well. Some areas of DNA, such as GC‑rich regions or repetitive sequences, are harder to sequence accurately.

This can lead to missed variants if coverage is too low.

4. Limited Detection of Certain Variant Types

Although NGS detects many variation types, some changes are still challenging:

• large structural variants
• complex chromosomal rearrangements
• repeat expansions (e.g., Huntington disease)

Specialised techniques may be needed alongside NGS to detect these variants properly.

5. Technical and Laboratory Requirements

NGS requires:

• expensive sequencing platforms
• controlled laboratory conditions
• highly trained technical staff

Not all clinics or hospitals have access to this infrastructure, which may limit availability in some regions.

6. Cost Considerations

While NGS is cost‑effective for large genomic regions, the initial investment in equipment, software, and personnel can be high.

Additionally, data storage and long‑term archiving increase ongoing costs.

7. Ethical and Clinical Interpretation Challenges

Clinical use of NGS often identifies:

• variants of uncertain significance (VUS)
• incidental or unexpected findings
• results with unclear or evolving clinical meaning

These findings require careful explanation, usually through genetic counselling, to help patients understand the results and their implications.